The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa

Krishna R. Veeramah, Mark G. Thomas, Michael E. Weale, David Zeitlyn, Ayele Tarekegn, Endashaw Bekele, Nancy R. Mendell, Elizabeth A. Shephard, Neil Bradman, Ian R. Phillips
  • Pharmacogenetics and Genomics, October 2008, Wolters Kluwer Health
  • DOI: 10.1097/fpc.0b013e3283097311

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor David Zeitlyn